T. Roszman

发表

Suppression of lymphocyte function by products derived from cigarette smoke.

T. Roszman, L. Elliott, A. S. Rogers, 1975, The American review of respiratory disease.

Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis.

W. Markesbery, T. Roszman, W. Brooks, 1982, Immunology.

Tubulin Polymerization Modulates Interleukin-2 Receptor Signal Transduction in Human T Cells

T. Roszman, M. Wills-Karp, J. Goebel, 2006, Journal of receptor and signal transduction research.

Primary Malignant Brain Tumors

T. Roszman, L. Elliott, W. Brooks, 2004 .

Immune defects observed in patients with primary malignant brain tumors

T. Roszman, W. Brooks, L. Morford, 1999, Journal of Neuroimmunology.

Interstitial nephritis, hepatic failure, and systemic eosinophilia after minocycline treatment.

T. Roszman, J. Goebel, K. Forrest, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Lipid rafts in cytokine signaling.

T. Roszman, J. Goebel, K. Forrest, 2004, Cytokine & growth factor reviews.

Proliferative potential of T-cell lymphocytes from gliomas.

T. Roszman, L. Elliott, W. Brooks, 1992, Journal of neurosurgery.

Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours.

T. Roszman, M. Mahaley, W. Brooks, 1977, Clinical and experimental immunology.

Impairment of rosette‐forming T lymphocytes in patients with primary intracranial tumors

T. Roszman, A. S. Rogers, W. Brooks, 1976, Cancer.

Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours.

T. Roszman, W. Brooks, 1980, Clinical and experimental immunology.

Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

T. Roszman, L. Elliott, L., 1990, The Journal of clinical investigation.

Monocyte Cytokine Profile and Surface Involves Soluble Factor(s) That Alters Human Glioma-Induced Immunosuppression

J. Coligan, T. Roszman, J. Shuman, 2013 .

Markers Monocyte Cytokine Profile and Surface Involves Soluble Factor ( s ) That Alters Human Glioma-Induced Immunosuppression Gene

J. Coligan, T. Roszman, J. Shuman, 1999 .

Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells.

T. Roszman, J. Goebel, K. Forrest, 2002, Biochemical and biophysical research communications.

Modulation of T-cell function by gliomas.

T. Roszman, L. Elliott, W. Brooks, 1991, Immunology today.

Functional characterization of the insulin-like growth factor I receptor on Jurkat T cells.

T. Roszman, L. Elliott, L. Morford, 1995, Cellular immunology.

T-lymphocyte heterogeneity in rat: role of adherent T-cell subpopulation in the regulation of cytotoxic T-cell response to alloantigens.

T. Roszman, M. Sopori, W. Brooks, 1981, Cellular immunology.

Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation.

T. Roszman, W. Brooks, Mary M. Bartik, 1993, Cellular immunology.

Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethosone, isoproterenol, or prostaglandin E2 either alone or in combination

T. Roszman, L. Elliott, W. Brooks, 1992, Cellular and Molecular Neurobiology.

Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

D. Bigner, T. Roszman, S. Richardson, 1977, Journal of neurosurgery.

Calcium-dependent Signaling Pathways in T Cells

Michael T. Rock, T. Roszman, M. Rock, 1997, The Journal of Biological Chemistry.

Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation.

T. Roszman, W. Brooks, Mary M. Bartik, 1994, Cellular immunology.

Differential Compartmentalization of the Calpain/Calpastatin Network with the Endoplasmic Reticulum and Golgi Apparatus*

T. Roszman, Joshua L Hood, W. Brooks, 2004, Journal of Biological Chemistry.

Beta1 integrin-mediated T cell adhesion and cell spreading are regulated by calpain.

M. Rock, T. Roszman, W. Brooks, 2000, Experimental cell research.

Neural modulation of immune function

T. Roszman, W. Brooks, 1985, Journal of Neuroimmunology.

Patients with Cerebral Tumors

T. Roszman, L. Elliott, W. Brooks, 2006 .

Specific uptake of serotonin by murine macrophages.

T. Roszman, R. Walker, W. Brooks, 1988, Life sciences.

Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas.

T. Roszman, L. Elliott, W. Brooks, 1987, Journal of neurosurgery.

Lymphocyte subpopulations and responsiveness in rats bearing intracranial tumors induced by avian sarcoma virus.

D. Bigner, W. Markesbery, T. Roszman, 1981, Journal of neurosurgery.

Suppressor cell regulation of the spontaneously induced in vitro secondary antibody response.

T. Roszman, L. Elliott, 1978, Cellular immunology.

Dexamethasone and prostaglandin E2 modulate T-cell receptor signaling through a cAMP-independent mechanism.

T. Roszman, L. Elliott, M. Miller, 1996, Cellular immunology.

Lipid rafts, major histocompatibility complex molecules, and immune regulation.

T. Roszman, J. Goebel, K. Forrest, 2002, Human immunology.

Central Neural Circuits Involved in Neural–Immune Interactions

R. Ader, T. Roszman, S. Felten, 1991 .

Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production

T. Roszman, S. L. Carlson, W. Brooks, 1989, Journal of Neuroimmunology.

Hypothalamic-immune interactions Effect of hypophysectomy on neuroimmunomodulation

W. Markesbery, T. Roszman, W. Brooks, 1982, Journal of the Neurological Sciences.

Association of the calpain/calpastatin network with subcellular organelles.

T. Roszman, A. Sinai, Joshua L Hood, 2003, Biochemical and biophysical research communications.

Atorvastatin Affects Interleukin-2 Signaling by Altering the Lipid Raft Enrichment of the Interleukin-2 Receptor β Chain

T. Roszman, M. Wills-Karp, J. Goebel, 2005, Journal of Investigative Medicine.

Immunologic disparity in the hypopituitary dwarf mouse.

T. Roszman, R. Cross, J. S. Bryson, 1992, Journal of immunology.

Hypothalamic-immune interactions: neuromodulation of natural killer activity by lesioning of the anterior hypothalamus.

W. Markesbery, T. Roszman, W. Brooks, 1984, Immunology.

Proteolytic cleavage of alpha-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody.

T. Roszman, N. Selliah, W. Brooks, 1996, Journal of immunology.

Antigenic selection of IgG precursor subpopulations.

T. Roszman, L. Elliott, 1975, Journal of immunology.

Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor

T. Roszman, L. Elliott, W. Brooks, 1992, Journal of Neuro-Oncology.

cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization

T. Roszman, N. Selliah, S. L. Carlson, 1995, Journal of Neuroimmunology.

Enhancement of β‐Adrenergic‐induced cAMP accumulation in activated T‐Cells

T. Roszman, S. L. Carlson, W. Brooks, 1994, Journal of cellular physiology.

Effects of preincubating human peripheral blood lymphocytes on their ability to bind sheep red blood cells.

T. Roszman, W. Brooks, K. Muse, 1977, Journal of immunological methods.

Signaling pathways of the neuroendocrine-immune network.

T. Roszman, W. Brooks, 1992, Chemical immunology.

Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events.

T. Roszman, J. Goebel, K. Forrest, 2000, Transplant immunology.

Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review).

G. Duigou, P. Fisher, T. Roszman, 1990, Anticancer research.

Distinctions between rabbit lymph node cell populations responding to primary and secondary injections of keyhole limpet hemocyanin

T. Roszman, A. Stavitsky, J. Folds, 1971, Journal of cellular physiology.

Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas.

T. Roszman, L. Elliott, W. Brooks, 1987, Journal of the National Cancer Institute.

Modulation of T‐Suppressor cell activity by central nervous system catecholamine depletion

T. Roszman, W. Brooks, R. Cross, 1987, Journal of neuroscience research.

Behavioral conditioning of immunomodulation

T. Roszman, 1985, Behavioral and Brain Sciences.

Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland

T. Roszman, Jennifer L. Campbell, R. Cross, 1989, Journal of Neuroimmunology.

Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation

T. Roszman, R. Cross, 1988, Journal of Neuroimmunology.

Hypothalamic-immune interactions. I. The acute effect of anterior hypothalamic lesions on the immune response

W. Markesbery, T. Roszman, W. Brooks, 1980, Brain Research.

The Immune Status of Healthy Centenarians

D. Wekstein, T. Roszman, R. Straus, 1984, Journal of the American Geriatrics Society.

A kinetic and quantitative analysis of antibody and protein synthesis during the primary response to keyhole limpet haemocyanin.

T. Roszman, A. Stavitsky, J. Folds, 1971, Immunology.

Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment.

W. Markesbery, T. Roszman, W. Brooks, 1986, Immunology.

General immunocompetence of rats bearing avian sarcoma virus-induced intracranial tumors.

D. Bigner, W. Markesbery, T. Roszman, 1978, Cancer research.

Neuroanatomic and neurotransmitter influences on immune function.

W. Markesbery, T. Roszman, W. Brooks, 1985, Journal of immunology.

Relationship of lymphocyte invasion and survival of brain tumor patients

W. Markesbery, T. Roszman, W. Brooks, 1978, Annals of neurology.

Preparation of sensitive and stable erythrocytes by the carbodiimide method for the detection of primary and secondary IgM and IgG antibody.

D. L. Gunn, T. Roszman, 1972, Journal of immunological methods.

Analysis of the temporal changes in the avidity of primary IgM and IgG antibody at the cellular level.

T. Roszman, 1974, Cellular immunology.

Influence of serotonin on the immune response.

W. Markesbery, T. Roszman, R. Walker, 1985, Immunology.

Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.

J. Coligan, T. Roszman, J. Shuman, 1999, Journal of immunology.

Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.

T. Roszman, W. Brooks, L. Morford, 1999, Journal of neurosurgery.

T-lymphocyte heterogeneity in the rat: separation of distinct rat T-lymphocyte populations which respond in syngeneic and allogeneic mixed lymphocyte reactions.

T. Roszman, D. Cohen, A. Kaplan, 1984, Cellular immunology.

Immunobiology of primary intracranial tumors. Part 5: Correlation of a lymphocyte index and clinical status.

T. Roszman, R. Latta, M. Mahaley, 1981, Journal of neurosurgery.

Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor.

T. Roszman, L. Elliott, W. Brooks, 1987, Journal of Neurosurgery.

Insulin-like growth factors (IGF) enhance three-dimensional (3D) growth of human glioblastomas.

T. Roszman, E. Boghaert, W. Brooks, 1997, Cancer letters.

Interactive signaling pathways of the neuroendocrine-immune network.

T. Roszman, W. Brooks, 1997, Chemical immunology.

Subcellular mobility of the calpain/calpastatin network: an organelle transient.

T. Roszman, Joshua L Hood, W. Brooks, 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.

Neuroimmunomodulation: Neural anatomical basis for impairment and facilitation

W. Markesbery, T. Roszman, W. Brooks, 1982, Annals of neurology.

Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2

T. Roszman, L. Elliott, W. Brooks, 1993, Cellular and Molecular Neurobiology.

Differential localization of IL‐2‐ and ‐15 receptor chains in membrane rafts of human T cells

T. Roszman, J. Goebel, K. Forrest, 2002, Journal of leukocyte biology.

Neurotransmitters and Molecular Signaling in the Immune Response

T. Roszman, S. L. Carlson, 1981 .

Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.

T. Roszman, L. Elliott, W. Brooks, 1984, Journal of immunology.

Transplantation of pituitary grafts fail to restore immune function and to reconstitute the thymus glands of aged mice

W. Markesbery, T. Roszman, Jennifer L. Campbell, 1990, Mechanisms of Ageing and Development.

T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.

T. Roszman, L. Elliott, S. L. Carlson, 1997, Journal of immunology.

Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.

T. Roszman, W. Brooks, G. P. Bauman, 1994, Cellular immunology.

Some parameters of conditioned immunosuppression: Species difference and CS-US delay

T. Roszman, K. S. Kelly, James S. Miller, 1986, Physiology & Behavior.

Neuromodulation of lymphocyte reactivity in aged rats

W. Markesbery, T. Roszman, W. Brooks, 1984, Neurobiology of Aging.

Daclizumab therapy in kidney transplantation-different mechanisms of action in- versus ex-vivo?

T. Roszman, J. Goebel, K. Forrest, 2005, Transplant immunology.

Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function.

T. Roszman, L. Elliott, W. Brooks, 1985, Journal of immunology.

Immunobiology of primary intracranial tumors. VI. Suppressor cell function and lectin‐binding lymphocyte subpopulations in patients with cerebral tumors

T. Roszman, L. Elliott, W. Brooks, 1982, Cancer.

Suppression of the in Vitro Secondary Antibody Response of Rabbit Lymphoid Cells by Concanavalin A 1

T. Roszman, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Immunologic responses evoked by mycobacterial components. Disc elec-trophoretic separation of specific mycobacterial antigens.

W. L. Mallmann, T. Roszman, D. O'Reilly, 1968 .

Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors.

T. Roszman, L. Elliott, W. H. Brooks, 1990, The Journal of clinical investigation.